Health info/tech M&A slows down

A report from investment bank Berkery Noyes on M&A in information and tech companies serving pharma and healthcare says third-quarter transaction volume slowed 6% vs. Q2.

Transaction value rose 245%, a jump attributed to Blackstone Group's announced third-quarter acquisition of medical data services firm Emdeon for $3.03 billion, 2011's largest transaction so far. The quarter's most active acquirer was PerkinElmer.

“The need to integrate scientific tools, effectively manage knowledge, and organize workflow within laboratory settings is becoming even more crucial for clients of organizations such as PerkinElmer,” said managing director Jeffrey Smith.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.